APG Asset Management US Inc. Acquires 3,162 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

APG Asset Management US Inc. raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 120,453 shares of the company’s stock after acquiring an additional 3,162 shares during the quarter. APG Asset Management US Inc.’s holdings in GE HealthCare Technologies were worth $9,186,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. AQR Capital Management LLC boosted its holdings in shares of GE HealthCare Technologies by 3.8% during the 2nd quarter. AQR Capital Management LLC now owns 275,752 shares of the company’s stock valued at $21,487,000 after acquiring an additional 10,111 shares in the last quarter. AXA S.A. raised its position in GE HealthCare Technologies by 4.8% in the second quarter. AXA S.A. now owns 50,079 shares of the company’s stock valued at $3,902,000 after purchasing an additional 2,303 shares during the last quarter. Fred Alger Management LLC acquired a new stake in shares of GE HealthCare Technologies during the second quarter valued at about $26,000. Insigneo Advisory Services LLC grew its holdings in shares of GE HealthCare Technologies by 24.5% during the second quarter. Insigneo Advisory Services LLC now owns 6,519 shares of the company’s stock worth $531,000 after purchasing an additional 1,281 shares during the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its stake in shares of GE HealthCare Technologies by 69.4% in the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 82,856 shares of the company’s stock valued at $6,456,000 after buying an additional 33,938 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Trading Down 0.6 %

Shares of GEHC stock opened at $92.49 on Friday. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. The stock has a 50 day simple moving average of $84.90 and a two-hundred day simple moving average of $83.32. The company has a market cap of $42.22 billion, a P/E ratio of 27.04, a PEG ratio of 3.40 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating the consensus estimate of $0.98 by $0.02. The company had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. GE HealthCare Technologies’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.92 EPS. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their target price for the stock from $84.00 to $74.00 in a research report on Thursday. The Goldman Sachs Group assumed coverage on shares of GE HealthCare Technologies in a report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target on the stock. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a report on Wednesday, September 18th. Stifel Nicolaus started coverage on GE HealthCare Technologies in a report on Tuesday, August 6th. They set a “buy” rating and a $100.00 target price on the stock. Finally, JPMorgan Chase & Co. assumed coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price target on the stock. One analyst has rated the stock with a sell rating, five have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average price target of $93.92.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.